Cargando…

Author response to comment on: Alopecia in multiple sclerosis patients treated with disease modifying therapies

Detalles Bibliográficos
Autores principales:	Porwal, Mokshal H., Obeidat, Ahmed Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2022
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9527983/ https://www.ncbi.nlm.nih.gov/pubmed/36200126 http://dx.doi.org/10.1177/11795735221127131

Ejemplares similares

Alopecia in Multiple Sclerosis Patients Treated with Disease Modifying Therapies
por: Porwal, Mokshal H., et al.
Publicado: (2022)

Author response to: Correspondence to humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Achiron, Anat, et al.
Publicado: (2021)

Alopecia areata incognita: a comment
por: Rebora, Alfredo
Publicado: (2011)

An Author's Comment
por: Frankenburg, Charis U.
Publicado: (1962)

Author reply to comments
por: Bhalla, Ashu Seith, et al.
Publicado: (2015)

Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Piquet, Amanda L., et al.
Publicado: (2021)

Correspondence: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies
por: Petereit, Hela-Felicitas, et al.
Publicado: (2021)

Author reply to comment on photodynamic therapy and polypoidal choroidal vasculopathy
por: Williams, Gwyn Samuel, et al.
Publicado: (2014)

Authors’ Response to the Comments on “Specific Learning Disabilities: Issues that Remain Unanswered”
por: Kohli, Adarsh, et al.
Publicado: (2018)

Remission of idiopathic retroperitoneal fibrosis by ofatumumab as a disease-modifying therapy for multiple sclerosis
por: Hanazono, Akira, et al.
Publicado: (2022)

Low-Level Laser Therapy for Androgenic Alopecia
por: Tin, Sim Sai, et al.
Publicado: (2014)

Authors' response to comment on “International consensus on pressure injury preventative interventions by risk level for critically ill patients: A modified Delphi study”
por: Lovegrove, Josephine, et al.
Publicado: (2020)

Author Response: Comments on Evaluation of Central and Peripheral Visual Field Concordance in Glaucoma
por: Odden, Jamie L., et al.
Publicado: (2016)

Authors' Reply to Comments from Dr. Guan
por: Inoue, Ken-ichiro, et al.
Publicado: (2009)

Authors’ Reply to Comments on ASHAs’ Perceptions on Depression
por: Mary Kapanee, Aruna Rose, et al.
Publicado: (2018)

Giant Congenital Triangular Alopecia Mimicking Alopecia Areata
por: Kudligi, Chandramohan, et al.
Publicado: (2012)

Isoniazid and alopecia
por: Wiwanitkit, Somsri, et al.
Publicado: (2011)

Testosterone-Mediated Aggression in Angelman Syndrome Treated With Leuprolide and Orchiectomy
por: Anderson, Danyon J, et al.
Publicado: (2022)

Author response to ” Comment on: Photosensitivity and filter efficacy in albinism” JOPTOM-D-23-00096
por: Jordana, Joaquim Torner, et al.
Publicado: (2024)

Comment on “The role of Epstein-Barr virus in multiple sclerosis: from molecular pathophysiology to in vivo imaging”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Congenital Triangular Alopecia: A Close Mimicker of Alopecia Areata
por: Gupta, Lalit K, et al.
Publicado: (2011)

Proposition of a New Terminology of Senile Alopecia: Physiologic Alopecia
por: Bourezane, Yazid, et al.
Publicado: (2023)

Authors’ Response to Comments on “Prevalence and Factors Associated with Depression among Clinically Stable People Living with HIV/AIDS on Antiretroviral Therapy
por: Algoodkar, Sharanabasappa Ambaraya, et al.
Publicado: (2018)

Authors’ Response: Comment on: “Transversus Thoracic Muscle Plane Block for Attenuating the Haemodynamic Response to Median Sternotomy”
por: Walian, Ashish, et al.
Publicado: (2023)

Comments on the review article ‘Time trends in the incidence and prevalence of multiple sclerosis in Norway during eight decades’
por: Berg‐Hansen, P., et al.
Publicado: (2015)

Comment on “Alemtuzumab improves cognitive processing speed in active multiple sclerosis – a longitudinal observational study”
por: Asadollahzade, Elnaz, et al.
Publicado: (2022)

Author’s Reply: Comments on “Vitamin Pharmacogenomics: New Insight into Individual Differences in Diseases and Drug Responses”
por: Liu, Mou-Ze, et al.
Publicado: (2017)

Authors' responses to the comments on “Attitude, practice, behavior, and mental health impact of COVID-19 on doctors”
por: Chatterjee, Seshadri Sekhar, et al.
Publicado: (2020)

Author response to comment on: Re-thinking benign inflammation of the lactating breast: Classification, prevention, and management
por: Douglas, Pamela
Publicado: (2023)

Re: Comments on “Neuropsychological Comparison of Patients With Alzheimer’s Disease and Dementia With Lewy Bodies”: Author Response
por: Kang, Sungwoo, et al.
Publicado: (2023)

Radiation-induced Alopecia
por: Ali, Syed Yousuf, et al.
Publicado: (2010)

Alopecia due to cancer
por: Wiwanitkit, Somsri, et al.
Publicado: (2013)

Anterolateral Leg Alopecia
por: Srinivas, Sahana M, et al.
Publicado: (2016)

The Relevance of Selenium to Alopecias
por: Tortelly Costa, Violeta Duarte, et al.
Publicado: (2018)

COVID‐19 in dimethyl fumarate‐treated patients with multiple sclerosis
por: Mantero, Vittorio, et al.
Publicado: (2020)

COVID-19 in multiple sclerosis patients treated with dimethyl fumarate
por: Capone, Fioravante, et al.
Publicado: (2021)

Re: Comments on “Neuromuscular Ultrasonography of Cranial Nerves”: The Authors Respond
por: Tawfik, Eman A., et al.
Publicado: (2017)

Author response
por: Kshirsagar, V. Y., et al.
Publicado: (2013)

Adequate antibody response to BioNTech COVID vaccine in a multiple sclerosis patient treated with siponimod
por: Siddiqui, Gulnaz, et al.
Publicado: (2021)

Thionamide-Responsive Alopecia Areata in a 11 Year Girl
por: Sridhar, Subbiah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_3h3q9vre8itg5hncov8aunuvo7